XML 29 R19.htm IDEA: XBRL DOCUMENT v3.25.1
Lessor Leases
 3 Months Ended
Mar. 31, 2025
Leases [Abstract]  
Lessor Leases Lessor Leases
Sales-Type Leases
The Company enters into non-cancelable sales-type lease arrangements with the leases varying in length from one to ten years. The Company optimizes cash flows by selling a majority of its sales-type leases, other than those relating to U.S. government hospitals and SaaS and Expert Services products, including Central Pharmacy Dispensing Service and IV Compounding Service, to third-party leasing finance companies on a non-recourse basis. The Company generally has no obligation to the leasing company once the lease has been sold.
The following table presents the Company’s income recognized from sales-type leases:
Three Months Ended March 31,
20252024
(In thousands)
Sales-type lease revenues$5,818 $7,036 
Cost of sales-type lease revenues(2,937)(4,187)
Selling profit on sales-type lease revenues$2,881 $2,849 
The receivables as a result of these types of transactions are collateralized by the underlying equipment leased and consist of the following components:
March 31,
2025		December 31,
2024
(In thousands)
Net minimum lease payments to be received$77,528 $77,976 
Less: Unearned interest income portion(12,393)(12,757)
Net investment in sales-type leases65,135 65,219 
Less: Current portion (1)
(12,601)(12,475)
Long-term investment in sales-type leases, net$52,534 $52,744 
_________________________________________________
(1)    The current portion of the net investment in sales-type leases is included in other current assets in the Condensed Consolidated Balance Sheets.
The carrying amount of the Company’s sales-type lease receivables is a reasonable estimate of fair value.
The maturity schedule of future minimum lease payments under sales-type leases retained in-house and the reconciliation to the net investment in sales-type leases reported on the Condensed Consolidated Balance Sheets was as follows:
March 31,
2025
(In thousands)
Remaining nine months of 2025$12,156 
202614,608 
202713,145 
202812,049 
20299,441 
Thereafter16,129 
Total future minimum sales-type lease payments77,528 
Present value adjustment(12,393)
Total net investment in sales-type leases$65,135